This study offers a valuable methodological advance by introducing a gene panel selection approach that captures combinatorial specificity to define cell identity. The findings address key limitations ...
Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from ...
NewLimit raises $45 million in funding at $1.62B valuation to advance longevity research and restore youthful liver function.
Merck KGaA could now have a head start in the race to market Precem-TcT, which could become the first widely approved ADC in ...
Colorectal cancer is one of the most common tumours among people over the age of 50. Although it is known to develop from ...
Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...
Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony ...
Prostate cancer relies on genetic "switches," called enhancers, that can turn on tumor-promoting genes. Researchers at the ...
Following the event, a copy of the poster presentations will be available on the Company’s website at: https://prokidney.com/our-technology/publications/ Additional information on ASN Kidney Week 2025 ...
To help prevent oxidative stress, people need to eat foods with antioxidants and limit their exposure to oxidants, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback